Beyond Air to Present at Cantor Global Healthcare Conference

  • Beyond Air will participate in the 2026 Cantor Global Healthcare Conference on September 9-11.
  • The company's management team will hold a fireside chat on September 10 at 3:55 PM EDT.
  • A live webcast and replay will be available on Beyond Air's website for 90 days.
  • Beyond Air focuses on nitric oxide therapies for respiratory, neurological, and oncological conditions.

Beyond Air's participation in the Cantor Global Healthcare Conference underscores its push to engage institutional investors amid growing interest in nitric oxide-based therapies. The event provides a platform to highlight its FDA-approved LungFit PH system while navigating a competitive medical device and biopharmaceutical market. The strategic positioning comes as the company seeks to expand its commercial footprint in respiratory and oncological care.

Strategic Messaging
How Beyond Air frames its nitric oxide platform in a competitive healthcare landscape.
Investor Sentiment
Whether the presentation shifts market perception of Beyond Air's growth trajectory.
Pipeline Updates
The pace at which Beyond Air advances its regulatory-approved LungFit PH system.